Windtree Therapeutics Inc
WINT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$16
Close$
$-0.82
136400% downside
Current Fair Value
136400% downsideOvervalued by 136400% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $16.00 |
|---|---|
| Enterprise Value | $3.17 Million |
| Earnings per Share | $-104.35 |
| Beta | 1.73 |
| Outstanding Shares | 26,675 |
Return
| Return on Equity | -506155.56% |
|---|---|
| Return on Assets | -285.02% |
| Return on Invested Capital | 128.91% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 70.44 |
| Enterprise Value to EBIT | -0.42 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | 374.89 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 26, 2026
EPS Estimate
$-13500.00
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Windtree Therapeutics Inc
31 employees
Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franc...